NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
4.010
-0.220 (-5.20%)
Nov 24, 2025, 4:00 PM EST - Market closed
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $462.22 million as of November 25, 2025. Its market cap has increased by 425.55% in one year.
Market Cap
462.22M
Enterprise Value
300.08M
1-Year Change
425.55%
Ranking
Category
Stock Price
$4.01
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $462.22M, an increase of 234.82%. That is a compound annual growth rate of 22.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 462.22M | 567.76% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |